Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer

Rojo, F. ; García-Parra, J. ; Zazo, S. ; Tusquets, I. ; Ferrer-Lozano, J. ; Menendez, S. ; Eroles, P. ; Chamizo, C. ; Servitja, S. ; Ramírez-Merino, N. ; Lobo, F. ; Bellosillo, B. ; Corominas, J.M. ; Yelamos, J. ; Serrano, S. ; Lluch, A. ; Rovira, A. ; Albanell, J.

Oxford: Elsevier Ltd

Texto completo disponível

An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages

Huber-Ruano, I. ; Raventós, C. ; Cuartas, I. ; Sánchez-Jaro, C. ; Arias, A. ; Parra, J.L. ; Wosikowski, K. ; Janicot, M. ; Seoane, J.

England: Elsevier Ltd

Texto completo disponível

EGFR mutational status in determining choice of TKIs or standard chemotherapy for patients with advanced non-small cell lung cancer

Motta, L. ; Motta, G. ; Banna, G. ; Martorana, F. ; Longhitano, C. ; Inzerilli, N. ; Restuccia, N. ; Aiello, M. ; Soto Parra, H.J. ; Vigneri, P.

England: Elsevier Ltd

Texto completo disponível

ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort

Passaro, A. ; Metro, G. ; Tiseo, M. ; Migliorino, M.R. ; Santo, A. ; Sperandi, F. ; Maione, P. ; Puppo, G. ; Grossi, F. ; Soto Parra, H.J. ; Borra, G. ; Roca, E. ; Rocco, D. ; Stasi, I. ; Galetta, D. ; Carta, A.M. ; Milella, M. ; Fasola, G. ; Gebbia, V. ; Ferrari, S. ; De Marinis, F.

England: Elsevier Ltd

Texto completo disponível

766P Levels of serum EGF concentration as biomarker of response of CIMAvax-EFG vaccine: Survival evaluation of advanced NSCLC patients treated in primary health care scenario

Otiz Carrodeguas, R.A. ; Lorenzo Monteagudo, G. ; Guerra, P.P. ; Sanchez, L. ; Cárdenas, L. ; Álvarez, I. ; Salomón, E.E. ; Díaz, M. ; Menéndez, Y. ; Lobaina, L. ; Columbié, J.C. ; Camacho, K. ; Corella, M. ; Fardales, N. ; Parra, J. ; Viada, C. ; Saavedra, D. ; Santos, O. ; Crombet Ramos, T.

Texto completo disponível

Heritage, a phase III safety and efficacy trial of the proposed trastuzumab biosimilar, Myl-1401O vs trastuzumab

Rugo, H. ; Barve, A. ; Waller, C.F. ; Bronchud, M. ; Herson, J. ; Yuan, J. ; Manikhas, A. ; Bondarenko, I. ; Mukhametshina, G. ; Nemsadze, G. ; Parra, J.D. ; Abesamis-Tiambeng, M.L.T. ; Baramidze, K. ; Akewanlop, C. ; Vynnychenko, I. ; Sriuranpong, V. ; Mamillapalli, G. ; Ray, S. ; Ruiz, E.P. Yanez ; Pennella, E.

Elsevier Ltd

Texto completo disponível

Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer

Santoro, A. ; Cavina, R. ; Latteri, F. ; Zucali, P. A. ; Ginanni, V. ; Campagnoli, E. ; Ferrari, B. ; Morenghi, E. ; Pedicini, V. ; Roncalli, M. ; Alloisio, M. ; Ravasi, G. ; Soto Parra, H. J.

Oxford: Oxford University Press

Texto completo disponível

477TiP Phase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R)

Thongprasert, S. ; Alexandru, A. ; Schenker, M. ; Abdelaziz, A. ; Clement, D. ; Boldeanu, C. ; Jovanovic, D. ; Reyes-Igama, J. ; Petrović, M. ; Geater, S. ; Radosavljevic, D. ; Perin, B. ; Krzakowski, M. ; Serwatowski, P. ; Parra, J. ; Sriuranpong, V. ; Jones, H. ; Cseh, A. ; Gaafar, R.

Elsevier Ltd

Texto completo disponível

7O Updated results from phase I study of CC-90011 in patients (pts) with solid tumours (STs), including neuroendocrine neoplasms (NENs), and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; De Braud, F. ; Gonzalez de Villambrosía, S. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; De Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Elsevier Ltd

Texto completo disponível

528O CC-90011 in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory non-Hodgkin lymphoma (R/R NHL): Updated results of a phase I study

Hollebecque, A. ; de Bono, J.S. ; Salvagni, S. ; Plummer, R. ; Niccoli, P. ; Capdevila, J. ; Curigliano, G. ; Moreno, V. ; de Braud, F. ; López-Brea, M. ; Martin-Romano, P. ; Baudin, E. ; Arias, M. ; de Alvaro, J. ; Parra-Palau, J. ; Sánchez-Pérez, T. ; Aronchik, I. ; Filvaroff, E. ; Lamba, M. ; Nikolova, Z.

Elsevier Ltd

Texto completo disponível